Mittel zur Verwendung bei der Zellstoffgewinnung und Verfahren zur Zellstoffgewinnung
申请人:BAYER AG
公开号:EP0006201A1
公开(公告)日:1980-01-09
Die vorliegende Erfindung betrifft ein Mittel zur Verwendung bei der Zelisioffgewinnung, das organische, cyclische, Keto- und/oder Hydroxygruppen enthaltende Verbindungen in fein verteilter Form. Tenside und gegebenenfalls weitere Stoffe enthält, sowie ein Verfahren zur Zellstoffgewinnung unter Einsatz dieses Mtttels.
Process for the delignification of lignocellulosic material and products thereof
申请人:C.I.L. Inc.
公开号:EP0010451A1
公开(公告)日:1980-04-30
There is disclosed a process for the delignification of lignocellulosic material by treatment with an alkaline liquor in the presence of a cyclic keto compound such as anthraquinone. The lignocellulosic material in subdivided form is first impregnated with the alkaline liquor containing a suitable amount of the cyclic keto compound whereafter any excess liquor is drained. The impregnated material is then cooked by heating. The delignified products are suitable for the manufacture of paper.
Dispersion zur Verwendung bei der Zellstoffgewinnung und Verfahren zur Zellstoffgewinnung unter Verwendung dieser Dispersion
申请人:BAYER AG
公开号:EP0004928B1
公开(公告)日:1981-04-08
Tetracyanoanthraquinodimethane compounds and processes for the production thereof, polymers and charge-transfer complexes derived therefrom
申请人:MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
公开号:EP0061264B1
公开(公告)日:1985-07-24
DIPEPTIDYL PEPTIDASE-IV INHIBITORS
申请人:Kroth Heiko
公开号:US20100009961A1
公开(公告)日:2010-01-14
The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.